Therapeutic-dose heparin in preventing COVID-19–associated acute kidney injury: What about bleeding risk?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Therapeutic-dose heparin in preventing COVID-19–associated acute kidney injury: What about bleeding risk?

Published:2023-11 Issue:8 Volume:7 Page:102246
ISSN:2475-0379
Container-title:Research and Practice in Thrombosis and Haemostasis
language:en
Short-container-title:Research and Practice in Thrombosis and Haemostasis

Author:

Kow Chia Siang^ORCID,Thiruchelvam Kaeshaelya^ORCID

Publisher

Elsevier BV

Subject

Hematology

Reference3 articles.

1. Effect of therapeutic-dose heparin on severe acute kidney injury and death in noncritically ill patients hospitalized for COVID-19: a prespecified secondary analysis of the ACTIV4a and ATTACC randomized trial;Smilowitz;Res Pract Thromb Haemost,2023

2. Can renin-angiotensin system inhibitors protect against acute kidney injury in patients with COVID-19?;Kow;Crit Care Med,2022

3. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19;Ackermann;N Engl J Med,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP